Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
for tags : Als save search
BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
Published: 2024-04-09 (Crawled : 10:00) - prnewswire.com
BCLI | $0.5143 36K
|
Health Technology
|
| O: 10.45%
H: 0.0%
C: 0.0%
fda als cell for trial therapeutics agreement
AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
Published: 2024-04-03 (Crawled : 16:00) - globenewswire.com
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
health als granted canada
Health Canada Accepts for Review New Drug Submission for Tofersen for Treatment of Rare, Genetic Form of ALS
Published: 2024-03-19 (Crawled : 12:30) - biospace.com/
IONS | $40.98 0.42% 67K
|
Health Technology
|
| O: -0.33%
H: 1.89%
C: 0.64%
drug health genetic als review treatment canada submission
BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS
Published: 2024-02-23 (Crawled : 11:00) - prnewswire.com
BCLI | $0.5143 36K
|
Health Technology
|
| O: 8.93%
H: 6.33%
C: -3.06%
nurown fda als cell trial therapeutics
NeuroSense Receives U.S. FDA Confirmation of CMC Strategy for PrimeC in Preparation for Pivotal Phase 3 in ALS and Commercial Readiness
Published: 2023-11-13 (Crawled : 14:30) - prnewswire.com
NRSN | News | $1.52 13K
|
|
| O: 0.91%
H: 14.0%
C: -0.2%
fda primec als commercial
Pasithea Therapeutics Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets α5β1 Integrin for the Treatment of both Sporadic and Familial ALS
Published: 2023-11-09 (Crawled : 13:00) - globenewswire.com
KTTA | $7.15 11
|
|
| O: -3.9%
H: 4.05%
C: 4.05%
pas-003 antibody als treatment therapeutics
BrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALS
Published: 2023-10-18 (Crawled : 10:00) - prnewswire.com
BCLI | $0.5143 36K
|
Health Technology
|
| O: 5.0%
H: 0.53%
C: -2.86%
fda als cell nurown treatment therapeutics
Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union Following Re-Examination Process
Published: 2023-10-13 (Crawled : 00:20) - biospace.com/
AMLX | $2.015 1.77% 150K
|
|
| O: -3.75%
H: 2.83%
C: 2.18%
amx0035 chmp als treatment pharmaceuticals application negative
National Institutes of Health Awards $45.1 Million NINDS Grant for CNM-Au8® Study in ALSFunding to Support Research and Expanded Access of Investigational Drug in ALS
Published: 2023-10-05 (Crawled : 19:00) - biospace.com/
CLNN S | $0.3299 160K
|
|
| O: 4.43%
H: 27.91%
C: 5.31%
au8 drug health als awards research grant study
Coya Therapeutics Presents New Experimental Data Supporting the Mechanism of Action of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) at the 22nd Annual Northeast ALS (NEALS) Consortium Meeting
Published: 2023-10-05 (Crawled : 15:00) - biospace.com/
COYA | News | $8.44 3.3K
|
|
| O: 0.0%
H: 13.48%
C: 2.42%
als sclerosis treatment meeting therapeutics
National Institutes of Health Awards $45.1 Million NINDS Grant for CNM-Au8® Study in ALS
Published: 2023-10-05 (Crawled : 14:30) - globenewswire.com
CLNN S | $0.3299 160K
|
|
| O: 4.43%
H: 27.91%
C: 5.31%
au8 health als awards grant study
Path for BrainStorm ALS Treatment Remains Rocky, Hope for Others on Horizon
Published: 2023-09-29 (Crawled : 00:20) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
als hope treatment
Path for BrainStorm ALS Treatment Remains Rocky, Hope for Others on the Horiz...
Published: 2023-09-29 (Crawled : 21:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
als hope treatment
BrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALS
Published: 2023-09-28 (Crawled : 03:00) - prnewswire.com
BCLI | $0.5143 36K
|
Health Technology
|
| O: -48.44%
H: 6.38%
C: 1.39%
fda als review update cell nurown treatment meeting therapeutics
NeuroSense Granted Patents in Europe, Japan, and Israel for its ALS Drug PrimeC
Published: 2023-09-19 (Crawled : 13:00) - neurosense.investorroom.com
NRSN | News | $1.52 13K
|
|
| O: 4.56%
H: 1.15%
C: -3.78%
drug primec israel als granted
DarkPulse, Inc. JV Company, Neural Logistics, Seeks FDA Designation For ALS Patients
Published: 2023-08-01 (Crawled : 14:00) - globenewswire.com
DPLS | $0.0009 6.4M
|
Information
|
| O: -3.7%
H: 7.69%
C: 0.0%
fda als designation
BrainStorm Touts Biomarker Data for ALS Candidate After Two FDA Rebuffs
Published: 2023-07-10 (Crawled : 15:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
fda candidate als biomarker
Clene Announces Publication of Phase 2 CNM-Au8® Clinical Data for the Treatment of ALS in LANCET’s eClinicalMedicine
Published: 2023-06-26 (Crawled : 12:00) - globenewswire.com
CLNN S | $0.3299 160K
|
|
| O: 1.9%
H: 3.04%
C: -1.86%
au8 als publication treatment phase 2
Amylyx Pharmaceuticals Receives CHMP Negative Opinion on its Conditional Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union
Published: 2023-06-23 (Crawled : 14:00) - biospace.com/
AMLX | $2.015 1.77% 150K
|
|
| O: -1.65%
H: 0.0%
C: -5.38%
amx0035 chmp als treatment pharmaceuticals application negative
Amylyx Pharmaceuticals Provides Update on Ongoing Regulatory Review of AMX0035 for the Treatment of ALS in the European Union
Published: 2023-05-30 (Crawled : 13:00) - biospace.com/
AMLX | $2.015 1.77% 150K
|
|
| O: -4.63%
H: 8.23%
C: 1.52%
amx0035 als review update treatment ongoing pharmaceuticals
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
ZCMD | $2.18 50.35% 24M
|
Commercial Services
CHRO | $1.73 41.22% 46K
|
n/a
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
PRTG | $0.285 18.75% 140K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.